Evidence map›Paper›PMID 11371564›Full record

ArticleThe Journal of biological chemistry2001

The role of CDP in the negative regulation of CXCL1 gene expression.

C Nirodi, J Hart, P Dhawan, N S Moon, A Nepveu, A Richmond

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. International journal of molecular sciences · 2022
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Fine tuning the transcriptional regulation of the CXCL1 chemokine.Progress in nucleic acid research and molecular biology · 2003
    Review
  15. Role of CXCL1 in tumorigenesis of melanoma.Journal of leukocyte biology · 2002
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

C NirodiDepartment of Veterans Affairs, Nashville, Tennessee 37212, Vanderbilt University School of Medicine, Department of Cancer Biology, Nashville, Tennessee 37232, and the Molecular Oncology Group, McGill University, Montreal, Quebec H3A 1A1, Canada.
J Hart
P Dhawan
N S Moon
A Nepveu
A Richmond
Vanderbilt University · USMcGill University · CA

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
REGULATION OF EXPRESSION OF MGSA/GRO GENES IN MELANOMAR01CA056704 · NCI · VANDERBILT UNIVERSITY · PI RICHMOND, ANN · 1993 to 2001
$482k
NCI NIH HHS CA 56704NCI NIH HHS CA 68485NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA056704
6 · The paper itself

Abstract

The CXC chemokine, melanoma growth stimulatory activity/growth-regulated protein, CXCL1 is an important modulator of inflammation, wound healing, angiogenesis, and tumorigenesis. Transcription of CXCL1 is regulated through several cis-acting elements including Sp1, NF-kappa B, and an element that lies immediately upstream of the NF-kappa B element, the immediate upstream region (IUR). A transcription element data base search indicated that the IUR element contains a binding site for the transcriptional repressor, human CUT homeodomain protein/CCAAT displacement protein (CDP). It is shown here that in electrophoretic mobility shift assays, complexes obtained with the IUR oligonucleotide probe are supershifted by anti-CDP antibodies and that a CDP polypeptide containing a high affinity DNA binding domain binds to the sequence GGGATCGATC in the IUR element. In Southwestern blot analyses, oligonucleotides containing the wild-type IUR sequence, but not a mutant oligonucleotide with substitutions in the GGGATCGATC sequence, bind a 170--180-kDa protein. Furthermore, overexpression of the CDP protein blocks CXCL1 promoter activity in reporter gene assays, whereas overexpression of an antisense CDP construct leads to a significant increase in CXCL1 promoter activity. Mutations in the IUR element, which map in the putative CDP-binding site, inhibit the binding of CDP to the IUR element and favor increased transcription from the CXCL1 promoter. Based on these results, we propose that transcriptional regulation of the CXCL1 gene is mediated in part by CDP, which could play an important role in inflammatory processes and tumorigenesis.

Indexed as

Base SequenceGene Expression RegulationHomeodomain ProteinsHumansMolecular Sequence DataNuclear ProteinsPromoter Regions, GeneticReceptors, Interleukin-8ARepressor ProteinsTranscription FactorsTumor Cells, CulturedCUX1 protein, humanHomeodomain ProteinsNuclear ProteinsReceptors, Interleukin-8ARepressor ProteinsTranscription Factors

Identifiers

PMID11371564
PMCPMC2665279
OpenAlexW1982850154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.